Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Kallikrein 9 anticorps (N-Term)

KLK9 Reactivité: Humain WB, ELISA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN545342
  • Antigène Voir toutes Kallikrein 9 (KLK9) Anticorps
    Kallikrein 9 (KLK9)
    Épitope
    • 15
    • 7
    • 7
    • 6
    • 6
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reactivité
    • 33
    • 17
    • 6
    Humain
    Hôte
    • 49
    • 5
    Lapin
    Clonalité
    • 50
    • 4
    Polyclonal
    Conjugué
    • 21
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Kallikrein 9 est non-conjugé
    Application
    • 31
    • 23
    • 19
    • 13
    • 13
    • 7
    • 6
    • 5
    • 3
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Fonction
    Rabbit polyclonal antibody raised against synthetic peptide of KLK9.
     Réactivité croisée
    Humain
    Immunogène
    A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human KLK9.
    Top Product
    Discover our top product KLK9 Anticorps primaire
  • Indications d'application
    ELISA (1:1000)
    Western Blot (1:100-500)
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    In PBS (0.09 % sodium azide)
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C. For long term storage store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Diamandis, Yousef, Luo, Magklara, Obiezu: "The new human kallikrein gene family: implications in carcinogenesis." dans: Trends in endocrinology and metabolism: TEM, Vol. 11, Issue 2, pp. 54-60, (2001) (PubMed).

    Yousef, Kyriakopoulou, Scorilas, Fracchioli, Ghiringhello, Zarghooni, Chang, Diamandis, Giardina, Hartwick, Richiardi, Massobrio, Diamandis, Katsaros: "Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker." dans: Cancer research, Vol. 61, Issue 21, pp. 7811-8, (2001) (PubMed).

    Yousef, Diamandis: "The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9)." dans: Genomics, Vol. 65, Issue 2, pp. 184-94, (2000) (PubMed).

  • Antigène
    Kallikrein 9 (KLK9)
    Autre désignation
    KLK9 / Kallikrein-9 (KLK9 Produits)
    Synonymes
    anticorps KLK-L3, anticorps KLKL3, anticorps 1200016C12Rik, anticorps AI324041, anticorps Klk9, anticorps Klks3, anticorps rGK-9, anticorps rK9, anticorps kallikrein related peptidase 9, anticorps kallikrein related-peptidase 9, anticorps kallikrein 1-related peptidase C9, anticorps KLK9, anticorps Klk9, anticorps Klk1c9
    ID gène
    284366
    Pathways
    Système du Complément
Vous êtes ici:
Support technique